President and Chief Executive Officer · Generation Bio Co. (GBIO)

Geoff McDonough

A named executive officer of Generation Bio in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,808,274

Salary $655,301Stock awards $0

FY2023: $2,315,263

1st of 5 named executive officers at Generation Bio by FY2024 total.

5 named officers on file for Generation Bio, FY2024

Geoff McDonough’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • GBIO’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Generation Bio’s whole pay program stands against its peers

  • Generation Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GBIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Geoff McDonough’s full pay file as a PDF — free

More than this page: up to 10 years of Geoff’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Geoff McDonough compensation by year

Generation Bio Summary Compensation Table · all 3 fiscal years held
In US dollars, as Generation Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$605,863$630,097$655,301
Bonus$0$0$0
Stock awards$1,216,875$396,984$0
Option awards$1,810,800$904,896$790,358
Non-equity incentive$333,224$381,209$360,416
Pension and deferred compensation$0$0$0
All other$0$2,077$2,199
Total$3,966,762$2,315,263$1,808,274

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Generation Bio Co. DEF 14A filed April 23, 2025, accession 0001558370-25-005263, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Generation Bio Co. filed document, accession 0001558370-25-005263. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

$4.0M
$2.3M
$1.8M
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU47,459$50,307—
Option15,687—$30.25
Option117,185—$6.49
Option94,921—$4.71
Option120,234—$1.39
Option506,250—$1.86

Per the Outstanding Equity Awards at Fiscal Year-End table in Generation Bio Co.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

25 Form 4 lines since the FY2024 proxy (filed April 23, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-09U—22,646—0
2026-02-09U—27,500—0
2026-02-09Disposition to the issuer derivative—19,903—0
2026-02-09Disposition to the issuer derivative—25,099—0
2026-02-09Disposition to the issuer derivative—37,499—0
2026-02-09Disposition to the issuer derivative—50,624—0
2026-02-09Disposition to the issuer derivative—90,168—0
2026-02-09U—138,492—0

The 8 most recent of 25 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Generation Bio discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$656,352$12,577$0$1,029,923
Change in control and involuntary termination$984,528$50,307$0$1,576,325

Per the Potential Payments Upon Termination or Change in Control table in Generation Bio Co.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

Generation Bio’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Geoff McDonough · this pagePresident and Chief Executive Officer$1,808,274
Matthew StantonChief Scientific Officer$993,038
Antionette PaoneChief Operating Officer$931,962
Phillip SamayoaChief Strategy Officer$931,763
Matthew NorkunasChief Financial Officer$914,246

Board service

Generation Bio board · FY2024

How this board is paid

Company policy: Generation Bio pays directors a $40,000 cash retainer. As stated in Generation Bio's FY2024 proxy.

The full Generation Bio compensation record

free company brief

This page is one person within Generation Bio's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Generation Bio proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Generation Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Geoff McDonough's compensation dossier · One-time report. No refunds.